Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5938
-2.5 %
$ 152 M
Market Cap
-3.49
P/E
ADAP - STOCK-BASED COMPENSATION
Stock-based Compensation ADAP - Adaptimmune Therapeutics plc
11.8 M
LAST VALUE
-24.46%
2 YEAR CAGR
0.00%
5 YEAR CAGR
52.75%
10 YEAR CAGR